Literature DB >> 11036771

ILT receptors at the interface between lymphoid and myeloid cells.

M Cella1, H Nakajima, F Facchetti, T Hoffmann, M Colonna.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11036771     DOI： 10.1007/978-3-642-57276-0_20

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  10 in total

Review 1.  Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.

Authors:  Lu Deng; Roy A Mariuzza
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

2.  High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation.

Authors:  Ruth K Moysey; Yi Li; Samantha J Paston; Emma E Baston; Malkit S Sami; Brian J Cameron; Jessie Gavarret; Penio Todorov; Annelise Vuidepot; Steven M Dunn; Nicholas J Pumphrey; Katherine J Adams; Fang Yuan; Rebecca E Dennis; Deborah H Sutton; Andy D Johnson; Joanna E Brewer; Rebecca Ashfield; Nikolai M Lissin; Bent K Jakobsen
Journal:  Protein Cell       Date:  2011-01-08       Impact factor: 14.870

3.  Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state.

Authors:  Dror Tobi; Ivet Bahar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-14       Impact factor: 11.205

4.  Two Distinct Myeloid Subsets at the Term Human Fetal-Maternal Interface.

Authors:  Maria Laura Costa; Michelle L Robinette; Mattia Bugatti; Mark S Longtine; Bryanne N Colvin; Erica Lantelme; William Vermi; Marco Colonna; D Michael Nelson; Marina Cella
Journal:  Front Immunol       Date:  2017-10-25       Impact factor: 7.561

Review 5.  Turning enemies into allies-reprogramming tumor-associated macrophages for cancer therapy.

Authors:  Martina Molgora; Marco Colonna
Journal:  Med (N Y)       Date:  2021-06-15

6.  Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease.

Authors:  Rafael J Argüello; María C Albareda; María G Alvarez; Graciela Bertocchi; Alejandro H Armenti; Carlos Vigliano; Patricia C Meckert; Rick L Tarleton; Susana A Laucella
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

7.  CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.

Authors:  Emma J Petrie; Craig S Clements; Jie Lin; Lucy C Sullivan; Darryl Johnson; Trevor Huyton; Annie Heroux; Hilary L Hoare; Travis Beddoe; Hugh H Reid; Matthew C J Wilce; Andrew G Brooks; Jamie Rossjohn
Journal:  J Exp Med       Date:  2008-03-10       Impact factor: 14.307

Review 8.  Regulatory T cells and human disease.

Authors:  Nathalie Cools; Peter Ponsaerts; Viggo F I Van Tendeloo; Zwi N Berneman
Journal:  Clin Dev Immunol       Date:  2007

9.  Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.

Authors:  Benjamin E Willcox; Leonard M Thomas; Tara L Chapman; Astrid P Heikema; Anthony P West; Pamela J Bjorkman
Journal:  BMC Struct Biol       Date:  2002-10-11

10.  Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition.

Authors:  Philippa M Saunders; Phillip Pymm; Gabriella Pietra; Victoria A Hughes; Corinne Hitchen; Geraldine M O'Connor; Fabrizio Loiacono; Jacqueline Widjaja; David A Price; Michela Falco; Maria Cristina Mingari; Lorenzo Moretta; Daniel W McVicar; Jamie Rossjohn; Andrew G Brooks; Julian P Vivian
Journal:  J Exp Med       Date:  2016-04-04       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.